The Cooper Companies, Inc. (COO): Price and Financial Metrics
The Cooper Companies, Inc. (COO)
Today's Latest Price: $377.42 USD
Updated Jan 26 4:02pm
Add COO to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 188 in Medical - Devices & Equipment
See all "A" rated Strong Buy stocks
COO Stock Summary
- With a market capitalization of $18,846,319,014, Cooper Companies Inc has a greater market value than 88.74% of US stocks.
- COO's went public 35.09 years ago, making it older than 92.79% of listed US stocks we're tracking.
- With a price/earnings ratio of 79.05, Cooper Companies Inc P/E ratio is greater than that of about 87.62% of stocks in our set with positive earnings.
- Stocks that are quantitatively similar to COO, based on their financial statements, market capitalization, and price volatility, are XYL, STE, TFX, SNN, and ROL.
- Visit COO's SEC page to see the company's official filings. To visit the company's web site, go to www.coopercos.com.
COO Stock Price Chart Interactive Chart >
COO Price/Volume Stats
| Current price | $377.42 | 52-week high | $389.43 |
| Prev. close | $383.65 | 52-week low | $236.68 |
| Day low | $376.98 | Volume | 239,500 |
| Day high | $385.66 | Avg. volume | 284,163 |
| 50-day MA | $352.25 | Dividend yield | 0.02% |
| 200-day MA | $321.10 | Market Cap | 18.54B |
The Cooper Companies, Inc. (COO) Company Bio
The Cooper Companies operates through two business units. CooperVision is a global manufacturer providing products for contact lens wearers. CooperSurgical focuses on supplying women's health clinicians with products and treatment options to improve the delivery of healthcare to women. The company was founded in 1980 and is based in Pleasanton, California.
COO Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $377.42 | $22.22 | -94% |
We started the process of determining a valid price forecast for Cooper Companies Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Cooper Companies Inc ranked in the 9th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. As for the metrics that stood out in our discounted cash flow analysis of Cooper Companies Inc, consider:
- The company's debt burden, as measured by earnings divided by interest payments, is 8.24 -- which is good for besting 66.24% of its peer stocks (US stocks in the Healthcare sector with positive cash flow).
- Its compound free cash flow growth rate, as measured over the past 5.52 years, is -0.04% -- higher than only 20.02% of stocks in our DCF forecasting set.
- COO's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 3%; for context, that number is higher than 34.54% of tickers in our DCF set.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -94% |
| 1% | -94% |
| 2% | -94% |
| 3% | -94% |
| 4% | -94% |
| 5% | -94% |
BHC, EW, OSMT, SRDX, and NVST can be thought of as valuation peers to COO, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.
Loading social stream, please wait...